Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ALLOCompany Name
ALLOGENE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALLOGENE THERAPEUTICS INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ALLO - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 829K | 0% | $ 0 |
| 3/31/2025 | $ 785K | 0% | $ 0 |
| 12/31/2024 | $ 694K | 3154.55% | $ 22K |
| 9/30/2024 | $ 618K | 0% | $ -22K |
| 6/30/2024 | $ 201K | 957.14% | $ 21K |
| 3/31/2024 | $ 489K | 752.31% | $ 65K |
| 12/31/2023 | $ 1.52M | 1595.79% | $ 95K |
| 9/30/2023 | $ 3.03M | 1627.42% | $ 186K |
| 6/30/2023 | $ 3.24M | 1686.46% | $ 192K |
| 3/31/2023 | $ 4.32M | 1847.86% | $ 234K |
Key Performance Insights, Last 5 Years
- ALLOGENE THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx % stands at 0%.
- Over the past 5 years, ALLOGENE THERAPEUTICS INC's average CapEx % has been 1809.62%.
- The median CapEx % for ALLOGENE THERAPEUTICS INC during this period was 1627.42%
- ALLOGENE THERAPEUTICS INC reached its highest CapEx % over the past 5 years at 8237.56%.
- The lowest CapEx % recorded by ALLOGENE THERAPEUTICS INC in the same timeframe 55.72%
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for ALLOGENE THERAPEUTICS INC is calculated as follows: CapEx [ $ 62.67M ] / Revenues [ $ 0 ]
(=) CapEx % [ 0% ] ALLO - Capital Expenditures Margin, Last 5 years
55.72%
Minimum
Dec 31, 2021
8237.56%
Maximum
Mar 31, 2022
1809.62%
Average
1627.42%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |